Randomized, double-blind, placebo-controlled trial of tirilazad mesylate: a cooperative study in Europe, Australia, and New Zealand

Completed

Phase N/A Results

Summary of Purpose

To test whether treatment with tirilazad would reduce ischemic symptoms from vasospasm and improve overall outcome in patients with ruptured aneurysms.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 6 April 2001.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Trial Design

Prospective randomized, double-blind, vehicle-controlled trial of 1023 patients at 41 neurosurgical centers in Europe, Australia, and New Zealand.

Contacts

Not available